Abbott has initiated the TREAT TR post-market study of the TriClip transcatheter edge-to-edge repair (TEER) system for the treatment of tricuspid regurgitation (TR). The study is designed to evaluate the safety and performance of TriClip in a real-world setting and build on existing evidence concerning the safety and efficacy of the device in addressing TR. […] The post TriClip patients to be followed for five years in post-market study appeared first on Cardiovascular News .